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Introduction to Chronic Kidney Disease 
 
Chronic kidney disease (CKD) is defined as the slow loss of kidney function over time.1 The 
Centers for Disease Control and Prevention estimates that more than 1 in 10 adults, or over 20 
million people, in the United States currently have CKD.5 The disease is categorized into five 
stages which are ranked by severity, the last of which is called End Stage Renal Disease (ESRD). 
There is no cure for ESRD, so these patients depend on renal replacement therapy, either in the 
form of dialysis or a kidney transplant.1 In 2011 alone, more than 113,000 patients in the U.S. 
started undergoing maintenance dialysis treatments.5  
 
Healthy kidneys are responsible for removing waste products and excess water from the blood.1 
When the kidneys become compromised, a patient’s glomerular filtration rate (GFR) will 
decline. GFR is a commonly used measure of kidney damage, as it estimates how much blood is 
passing through the kidneys’ glomeruli each minute. In other words, GFR indicates the rate at 
which the kidneys are able to filter water and waste from the blood.37 The National Institute of 
Health diagnoses CKD in patients with a GFR <60 mL/min for 3 or more months.4 The most 
common causes of CKD are diabetes and hypertension, although other diseases and conditions 
can also harm the kidneys. These include, but are not limited to, polycystic kidney disease, 
kidney stones and infections, and toxic chemicals.1  
 
The consequences of CKD are many and spread throughout the body. As a result of excess fluid 
retention, patients with CKD develop high blood pressure, low blood cell count or anemia, and 
vitamin D deficiency. Bone health is also negatively impacted. Patients with ESRD typically 
undergo dialysis when they have only 10-15% of kidney function left.1 Dialysis has four major 
roles, in which it helps to (1) remove extra salt, water, and waste products from the body, (2) 
maintain safe levels of minerals and vitamins, (3) control blood pressure, and (4) produce red 
blood cells.2  
 
There are two types of dialysis, peritoneal dialysis (PD) and hemodialysis (HD). PD utilizes the 
peritoneum, or the membrane covering the walls of the abdomen. By inserting a catheter into the 
abdominal cavity and filling it with a hypertonic solution called dialysate, waste and fluids are 
drawn out of the blood through the peritoneum and into the solution. The waste solution is then 
drained from the body and disposed of.2 This is in contrast to HD, which uses a dialyzer or 
“artificial kidney.” In this mode of dialysis, patients are attached to a machine that passes their 
“dirty” blood through a dialyzer and dialysate solution. It then returns the newly filtered blood 
back to their bodies.3 
 
Another important aspect of CKD management involves what patients are eating. Depending on 
the stage of CKD and/or mode of dialysis, the renal diet requires patients to monitor, and 
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oftentimes restrict, their intake of phosphorus, potassium, and sodium.10 In general, CKD 
patients on dialysis require more protein and more calories than their non-dialysis counterparts.9 
This is in part due to the fact that 6-12 grams of amino acids, as well as other nutrients, are lost 
during each dialysis session. In addition, poor appetite and weight loss are common problems for 
chronic HD patients.18  
 
The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) 
recommends that maintenance HD patients consume at least 1.2 grams of protein per kilogram of 
body weight per day (g/kg/d), at least 50% of which should be of high biological value.9 This 
guideline was developed in part based on studies showing that a protein intake between 1.0-1.1 
g/kg/d is associated with a neutral nitrogen balance.23 In regards to energy intake, KDOQI 
recommends that individuals ≤60 years old consume 35 kcal/kg/d, while those >60 years old 
consume 30-35 kcal/kg/d. Similar to the guidelines concerning protein intake, it is thought that 
this level of energy intake is adequate in terms of inducing neutral nitrogen balance and 
maintaining serum albumin levels.9 Although controversial, hypoalbuminaemia, or low serum 
albumin, is commonly used to detect malnutrition in individuals undergoing HD.8 
 
Cardiovascular Disease, Malnutrition, and Inflammation in CKD 
 
According to a 2013 report by the U.S. Renal Data System, survival of maintenance HD patients 
has not improved substantially in the past two decades. In fact, almost two thirds of these 
patients die within five years of initiating chronic dialysis treatments. Most of these deaths are 
linked to cardiovascular disease (CVD).28 It is well established that patients with CKD have a 
significantly higher prevalence of CVD and higher mortality than non-CKD patients.6 The 
annual mortality rate due to CVD is 10- to 20- fold higher than in the general population, even 
when adjusted for age, gender, race, and the presence of diabetes mellitus.7  
 
Malnutrition and inflammation are also very prevalent in this patient population. It is estimated 
that 31-77% of CKD patients are malnourished,6 and 30-65% have chronic, low-grade 
inflammation.23 In contrast to the general population, a high body mass index (BMI) is 
associated with better survival in ESRD patients, despite the negative metabolic effects of 
obesity. In other words, the protective effects of obesity on nutritional status outweigh the 
increased risk for insulin resistance, diabetes, coronary calcification, and atherosclerosis.24    
 
Malnutrition-inflammation is thought to have both CKD-related and non CKD-related origins. 
Elevated levels of urea in the blood, non-sterile dialysate, bio-incompatible membranes, and 
vascular access infections often plague CKD patients undergoing dialysis. Chronic heart failure, 
tobacco use, insulin resistance, elevated fat mass, and hypertension occur in both CKD and non-
CKD patients. Whatever the cause, these factors contribute to increased levels of cytokines (for 
example, tumor necrosis factor-α, interleukin-1, and interleukin-6) and reduced appetite and 
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intake. This is turn can lead to muscle wasting, weight loss, and decreased white blood cell 
count. Patients with moderate to severe CKD often have reduced total cholesterol as well, and 
studies show that low cholesterol levels in these patients consistently correlate with increased IL-
1 and TNF-α levels.6 In addition, inflammation contributes to decreased albumin synthesis by the 
liver and an increase in the albumin fractional catabolic rate.18  
 
Much of the existing research indicates that the presence of malnutrition in CKD patients cannot 
be determined by a single value. Instead, a larger panel of measurements is recommended, 
including measures of body mass and composition, dietary protein and energy intake, and serum 
protein status.20 A study by Thijssen et al. (2015) explored the benefits of using a “composite 
nutritional score” to diagnose malnutrition, which included serum albumin, serum phosphate, 
serum creatinine, equilibrated normalized protein catabolic rate (enPCR), and interdialytic 
weight gain (IDWG). Although the authors admit that this method requires further validation, a 
comprehensive score has advantages. Not only is it easier to track in practice, as opposed to 
following multiple clinical parameters, each component of the score represents a unique aspect 
of nutrition.29   
 
Fouque et al. (2011) compiled 11 clinical criteria commonly used to diagnose protein-energy 
wasting (PEW). As illustrated in Table 1 below, the criteria are split into four categories: serum 
chemistry, body mass, muscle mass, and dietary intake.23 
 
Table 1: Criteria for clinical diagnosis of PEW23 
Serum chemistry 
Serum albumin <3.8 g/dL 
Serum prealbumin <30 mg/dL (in HD patients) 
Serum cholesterol  <100 mg/dL 
Body mass 
BMI <23 kg/m2 
Unintentional weight loss 5% over 3 mo. or 10% over 6 mo.  
Total body fat percentage <10% 
Muscle mass 
Muscle wasting Reduced by 5% over 3 mo. or 10% over 6 mo. 
Reduced mid-arm circumference area >10% reduction 
Creatinine appearance  N/A 
Dietary intake 
Unintentional low protein intake <0.8 g/kg/d for 2 months (in HD patients) 
Unintentional low energy intake <25 kcal/kg/d for 2 mo. 
 
Although frequently used in clinical practice, numerous studies indicate that relying on serum 
proteins as markers of malnutrition is problematic. This in part due to the fact that the synthetic 
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rates of serum albumin, prealbumin, and retinol-binding protein are vulnerable to the effects of 
inflammation.7 A study by Gama-Axelsson et al. (2012) found that serum albumin correlates 
with age, diabetes, and C-reactive protein (CRP) levels but less so with markers of poor 
nutrition, such as lean body mass and handgrip strength. Consequently, they concluded that 
serum albumin’s reliability as a predictor of nutritional status in dialysis patients is limited. In 
addition, high serum albumin levels are observed even in cases of marasmus, or protein-energy 
malnutrition, and severe anorexia. Although this may be partly explained by albumin’s long half-
life (20 days) and its abundance in the body, low serum albumin levels are likely a better 
indication of illness as opposed to malnutrition.25,38   
 
Serum prealbumin is another measure used to determine nutritional status. As prealbumin has a 
significantly shorter half-life (2-3 days) than albumin, it is proposed that it may be a more 
sensitive indicator of nutritional status and mortality risk. Chertow et al. (2000) discovered that 
for every 1 mg/dL increase in prealbumin there was a 6% decrease in mortality risk. In addition, 
they found that the risk of death increased in individuals with serum prealbumin <25 mg/dL, 
regardless of whether serum albumin was high or low.26  
 
Although serum prealbumin may predict survival in maintenance HD patients, it has also been 
shown to decrease in the presence of inflammation. Therefore, the usefulness of both albumin 
and prealbumin as discrete markers of malnutrition is undermined by the fact that they reflect 
acute phase reactants in addition to the visceral protein pool.26  
 
Examining the Utility of normalized Protein Catabolic Rate  
 
Although difficult to measure, low dietary protein intake is associated with an increased risk of 
death among HD patients. Consequently, a variety of equations have been developed in order to 
estimate protein intake in this population. Protein catabolic rate (PCR), also known as protein 
equivalent of nitrogen appearance (PNA), is defined as the rate of increase in serum urea 
nitrogen levels between two HD treatments. In other words, it compares the levels of urea 
nitrogen in the body before and after dialysis.11 PCR is expressed as grams of net protein 
degradation per kilogram of body weight per day (g/kg/d), and can therefore be loosely 
interpreted as an estimate of dietary protein intake. Although there are numerous equations used 
to calculate PCR, it is most commonly calculated using Kt/V, a measure of dialysis adequacy, 
and both pre- and post- dialysis blood urea nitrogen concentrations (BUN).12  
 
The following equation was specifically developed for patients undergoing HD three times per 
week. It includes an additional factor KR, or a measure of residual renal clearance, as well as 
constants a and d, which are specific to each dialysis session of the week.35 Residual renal 
function is important to take into account, as nPCR will be underestimated otherwise.36 The 
factor 0.17 is derived from the inclusion of urea generation rate and a normalization factor, or 
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[Vurea/0.58]. The mean urea distribution volume [Vurea] is divided by 0.58, as the percentage of 
water in lean body mass is approximately 58%.35 The normalization coefficient is meant to 
represent the patients’ ideal body weight, as opposed to their actual body weight. This allows for 
comparison of nPCR values among patients over a wide range of body sizes.35,36 The equation by 
Garred et al. (1997) is as follows: 
 𝑛𝑃𝐶𝑅 = 𝑎 𝐾𝑡𝑉 +  𝑑𝐾!𝑉 𝐵𝑈𝑁!"# +  𝐵𝑈𝑁!"#$ + 0.17 
 
Therefore, normalized PCR (nPCR), reported in grams of urea nitrogen per kilogram per day, is 
considered to be a marker of steady-state protein intake in stable HD patients.29 Patel et al. 
(2000) followed 17 HD patients over 8 months and found that dietary supplement use in stable, 
chronic HD patients significantly increased both nPCR and total protein intake.14 Studies also 
show that a low nPCR typically reflects decreased dietary protein intake, while a very high nPCR 
may indicate tissue catabolism.29 Kim et al. (2013) examined correlates of low serum albumin 
(defined as <3.8 g/dL), including markers of dietary intake and inflammation. They found that 
the concentration of serum albumin increases with increasing nPCR up to around 1.4 g/kg/d, at 
which point albumin drops off.17  
 
Although nPCR allows for comparison among patients over a wide range of body sizes, it is only 
a single pool measurement; therefore, nPCR may overestimate urea clearance. Equilibrated 
nPCR (enPCR), on the other hand, is a double pool measurement that incorporates the impact of 
“urea rebound.” In other words, enPCR accounts for urea in the intracellular space as well as in 
the extracellular space, or circulating blood volume. It is slightly lower than nPCR, and is 
thought to provide a more accurate picture of protein breakdown.34,36 It should be noted that most 
of the existing literature has only examined nPCR, despite the use of enPCR in clinical practice.  
 
In Support of normalized Protein Catabolic Rate 
 
Many studies have attempted to determine the usefulness of PCR and nPCR in predicting protein 
intake, nitrogen balance, and mortality in maintenance HD patients. Shinaberger et al. (2006) 
followed a two-year cohort of 53,933 maintenance HD patients from DaVita clinics across the 
U.S. in order to determine the effects of low protein intake on mortality risk. Comorbidities, 
dialysis dose and adequacy, nPCR, and available markers of malnutrition-inflammation were all 
considered in the analysis. They found that both a low dietary protein intake (<0.8 g/kg/d) and a 
decrease in intake over time are associated with increased mortality, and concluded that the best 
survival is linked to nPCR values of 1.0-1.4 g/kg/d.13 Similar to findings by Kim et al. (2013), 
they determined that a nPCR of >1.4 g/kg/d is associated with greater mortality.13,17  
 
A study by Segall et al. (2009) also found decreased nPCR to be a risk factor for death. For every 
0.1 g/kg/d increase in nPCR, death risk decreased by 15%. Advanced age (>55 years old), a 
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lower subjective global assessment (SGA) score, and diabetes were also determined to 
significantly increase patients’ risk of death.15 The SGA is a widely used assessment tool that 
uses 5 components of medical history (weight change, dietary intake, gastrointestinal symptoms, 
functional capacity, disease and its nutritional requirements) and 3 components of a physical 
examination (signs of fat and muscle wasting, alternations in fluid balance) to evaluate 
nutritional status.39 This study’s reliability is limited by its sample size; it followed a total of 149 
maintenance HD patients at one dialysis center in Romania.15  
 
Ravel et al. (2013) examined the association between PCR, nPCR, and mortality. This 8-year 
prospective cohort study followed 98,489 maintenance HD patients across the U.S. They found 
that a low PCR (<30 g/kg/d) is associated with higher all-cause mortality, even after controlling 
for a variety of demographic and laboratory variables (age, gender, serum albumin, diabetes, 
race/ethnicity). Similar to other studies, they also found that a very high nPCR (>1.3 g/kg/d) is 
associated with increased all-cause mortality. The authors of this study suggest the later result 
may be a consequence of the toxic effects of a very high-protein diet, or a hypercatabolic state 
due to inflammation. Other explanations include a confounding effect of low body weight or 
poor compliance to medical prescription.28     
 
A prospective cohort study by Kalantar-Zadeh et al. (2003) found that both nPCR and serum 
albumin predict hospitalizations and mortality in HD patients with adequate or high Kt/V 
(defined as >1.20). The authors included Kt/V in the analysis in order to rule out other, 
potentially confounding, causes of the correlation between low nPCR and poor outcomes; for 
instance, uremia, low Kt/V, or the mathematic coupling of nPCR and Kt/V. 122 HD patients 
from a single dialysis unit were evaluated, all of whom had been undergoing treatment for one 
month to 17 years. Low nPCR and serum albumin levels were each found to have statistically 
significant correlations with mortality, as well as total days of hospitalization, total number of 
hospitalizations, and time to first hospitalization.16 
 
Lukowsky et al. (2014) followed a cohort of 17,445 incident HD patients at one DaVita clinic for 
the first two years of dialysis therapy. In order to account for serum albumin’s relationships to 
both nutritional status and inflammation, they categorized patients into four groups: (1) high 
nPCR and low serum albumin, (2) low nPCR and high serum albumin, (3) low nPCR and low 
serum albumin, and (4) high nPCR and high serum albumin. The authors hypothesized that 
nPCR correlates more closely with nutritional status than does serum albumin. Similar to 
Kalantar-Zadeh et al. (2003), they found that low serum albumin (<3.5 g/dL) and low nPCR 
(<1.0 g/kg/d) are consistently associated with high mortality. In addition, they found that a 0.2 
g/kg/d rise in nPCR shows a reverse effect on mortality, but only for the first 6-9 months. The 
authors suggest that very high nPCR values (>1.4 g/kg/d) or a rapid increase in nPCR may 
indicate negative nitrogen balance, an increased catabolic rate due to infection, or inflammation. 
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Therefore, they suggest close monitoring and evaluation for PEW in patients with an elevated 
nPCR, decreased serum albumin, decreased serum creatinine, and weight loss.18  
 
Limitations of normalized Protein Catabolic Rate  
 
Numerous other studies highlight the limitations of using nPCR in clinical practice. Shinaberger 
et al. (2006) points out that the associations between nPCR and mortality decrease substantially 
when the results are adjusted for markers of malnutrition-inflammation. Consequently, it is 
unclear whether the relationship between protein intake and survival is caused by, or is a 
consequence of, anorexia secondary to malnutrition-inflammation.13 In addition, nPCR does not 
differentiate between protein derived from dietary sources and that derived from catabolism of 
endogenous proteins.22 
 
Another major critique of nPCR is that it is only considered a valid indicator of protein intake 
under steady-state conditions. In other words, it does not accurately reflect protein intake in 
patients who are under- or over- nourished, or in a state of fluid imbalance. In addition, Kim et 
al. (2013) suggests that nPCR may in fact overestimate protein intake in inflammatory states due 
to increases in nitrogenous protein breakdown.17 Other studies point out that some nPCR 
calculations fail to take all nitrogen lost into account. The nitrogen in urea, creatinine, and uric 
acid is only about 94% of total nitrogen lost; there is also some nitrogen lost through skin, 
breathing, and urine. Although many ESRD patients stop urinating all together, this may affect 
those HD patients with residual renal function. In addition, more amino acids and protein are lost 
into the dialysate solution as a result of dialyzer reuse, a practice that is still utilized by some 
dialysis clinics.19  
 
It has also been shown that nPCR is in part determined by other dialysis-related measures not 
considered in the calculations. Bastani et al. (1996) retrospectively reviewed the charts of 70 HD 
patients in one dialysis unit and found that moderate to severe reductions in serum concentrations 
of bicarbonate significantly impact protein catabolism in stable HD patients. Along with 
underscoring the importance of maintaining normal acid-base homeostasis in these patients, this 
finding indicates that variables other than protein intake affect nPCR. The authors also found that 
changes in dialysis delivery and adequacy (measured by Kt/V) and uremia (measured by mid-
week BUN) are independent determinants of nPCR.22  
 
A study by Kloppenburg et al. (1999) found that a single nPCR measurement is unreliable when 
assessing dietary protein intake. The authors evaluated 50 stable HD patients and discovered that 
a mean of three nPCR values correlates significantly with protein intake, while there is a notable 
lack of correlation between a single nPCR value and dietary protein intake. Dietary protein 
intake was estimated with 7-day food records and averaged over the entire week. Therefore, due 
to session-to-session variations in the urea reduction ratio (URR), Kt/V, and urea distribution 
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volume, a single nPCR measurement will give an inaccurate picture of a patient’s true protein 
intake.21 
 
Lastly, there is debate over how nPCR is calculated from PCR. In theory, the patient’s dry body 
weight is close to his or her ideal body weight and will therefore preserve a body composition 
ratio of approximately 0.73 (lean body mass to dry body weight).30 In reality, this is not always 
the case, and so numerous other equations have been developed, using standard body weight, 
adjusted body weight, or body weight derived from urea distribution volume.35 In conclusion, 
nPCR can be misleading in obese, malnourished, or edematous individuals due to a skewed ratio 
of lean body mass to dry body weight.17,35 
 
Implications for Practice 
 
In order to gain real-time perspective on the utility of enPCR in clinical practice, I first asked 
three dietitians at hemodialysis clinics in the Minneapolis-St. Paul area the following question: 
How useful do you feel enPCR is in predicting protein intake and protein-energy malnutrition in 
maintenance HD patients? Two main themes emerged from these conversations. Firstly, the 
dietitians expressed that they do not feel well informed on enPCR, in terms of how it is defined, 
how it should be interpreted, or how it is calculated. Overall, they have received minimal 
education regarding enPCR; therefore, they typically provide patients with a brief explanation 
only when asked. Secondly, they do not feel confident using enPCR as an indication of patients’ 
protein intake, due to its many limitations. As one of the dietitians pointed out, a large 
percentage of patients at her clinics are either fluid overloaded or obese.  
 
Regardless of the extent to which enPCR is actually utilized, it is tracked on a month-to-month 
basis in many dialysis clinics. It is also shown on the monthly lab reports reviewed with patients 
alongside serum albumin, the primary malnutrition marker used by renal dietitians. The “ideal” 
enPCR for HD patients is considered to be 1.14 g/kg/d.36 
 
I then conducted a mini-analysis with a sample of 30 maintenance HD patients. A total of 15 
men and 15 women, with an average age of 60 years, were randomly selected from one Fresenius 
Medical Care dialysis clinic in the Minneapolis-St. Paul area. Results were compiled into Table 
2. Names and other patient identifiers were removed from all anthropometric and biochemical 
data in order to protect patient privacy. All enPCR values were ranked from lowest to highest 
and split into three sections: (1) <0.8 g/kg/d, (2) 0.8-1.3 g/kg/d, and (3) >1.3 g/kg/d. In addition 
to enPCR, nPCR, and serum albumin, information regarding body weight, fluid gains, and 
nutritional status was also collected. The malnutrition risk score is a comprehensive score that is 
determined by a combination of factors. These include unplanned weight loss, current visceral 
protein stores (measured by serum albumin levels), appetite and/or current intake, and frequency 
of symptoms affecting intake (whether they be gastrointestinal, medication-related, or 
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psychosocial factors). My personal experience at this HD clinic indicates that dietitians most 
closely monitor those patients with the lowest serum albumin and malnutrition risk scores. 
 
Table 2: Comparisons of enPCR, nPCR, & Serum Albumin in 30 HD Patients 
enPCR 
(g/kg/d) 
nPCR 
(g/kg/d) 
Serum Albumin 
(g/dL) 
Age 
(yrs) 
Gender BMI 
(kg/m2)* 
Average % 
IDWG 
Malnutrition 
Risk Score** 
 
0.53 0.58 3.9 62 F 25 1.7 15 
0.62 0.66 3.1 54 F 35 3.1 9 
0.63 0.69 3.9 42 F 17 5.0 14 
0.64 0.67 4.0 68 M 28 3.8 16 
0.66 0.68 4.3 65 M 29 3.6 16 
0.69 0.73 4.4 64 M 25 2.6 16 
0.72 0.77 4.0 87 M 33 2.3 16 
0.72 0.79 4.2 71 M 24 3.7 16 
0.73 0.78 3.9 56 F 33 1.2 15 
0.74 0.78 4.0 63 M 21 3.4 15 
0.75 0.79 4.2 43 F 35 2.5 13 
0.76 0.82 3.3 69 M 28 2.0 15 
0.79 0.83 3.3 78 F 26 3.5 14 
 0.85 0.93 3.2 66 M 28 2.8 15 
0.89 0.94 4.1 50 F 20 2.0 15 
0.92 0.99 3.8 72 M 28 2.7 14 
0.93 1.00 4.2 40 F 17 3.4 16 
0.94 1.02 4.0 64 M 28 2.1 15 
0.95 1.00 3.5 87 F 21 3.0 11 
0.99 1.03 3.2 60 F 31 3.5 13 
1.01 1.09 4.1 56 M 35 4.0 14 
1.03 1.12 3.8 47 M 26 2.2 15 
1.06 1.12 4.1 57 M 31 4.9 16 
1.25 1.32 3.7 35 M 23 3.4 9 
1.28 1.34 4.0 26 F 34 3.8 15 
 1.31 1.37 3.6 72 M 24 4.5 10 
1.33 1.40 3.6 68 F 22 2.7 14 
1.40 1.49 4.1 43 F 22 4.4 15 
1.53 1.60 3.9 75 F 29 2.9 13 
1.56 1.81 4.0 53 F 21 4.2 15 
*BMI categories: <20 = malnutrition; 20-24 = ideal; 25-27 = overweight; >27 = obesity 
**Malnutrition risk score defined as follows: 14-16 = well-nourished; 11-13 = mild malnutrition 
risk; 8-10 = moderate malnutrition risk; ≤7 = severe malnutrition risk   
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Examining Table 2, no clear trends can be seen between enPCR and any of the other variables. If 
enPCR is truly an indication of protein intake in HD patients, one might expect to see a 
correlation between lower malnutrition risk scores and lower enPCR values, but this is not the 
case. In addition, serum albumin levels of 4.0 g/dL and higher can be seen in all three of the 
enPCR categories. This calls into question the ability of enPCR to predict mortality risk, despite 
what previous studies have shown.  
 
As indicated in the existing literature, enPCR is a less accurate measure in patients who are 
obese, otherwise nutritionally compromised, and/or gaining too much fluid in between HD 
treatments. Therefore, patients meeting the following criteria were excluded from further 
analysis: (1) BMI >27 kg/m2, (2) average IDWG ≥5%, and/or (3) malnutrition risk score ≤13. 
The data for the remaining 11 patients, who are considered to be more “stable,” is shown below 
in Table 3.  
 
Table 3: Comparisons of enPCR, nPCR, & Serum Albumin in 11 Stable HD Patients 
enPCR 
(g/kg/d) 
nPCR 
(g/kg/d) 
Serum Albumin 
(g/dL) 
Age 
(yrs) 
Gender BMI 
(kg/m2)* 
Average % 
IDWG 
Malnutrition 
Risk Score** 
 
0.53 0.58 3.9 62 F 25 1.7 15 
0.69 0.73 4.4 64 M 25 2.6 16 
0.72 0.79 4.2 71 M 24 3.7 16 
0.74 0.78 4.0 63 M 21 3.4 15 
0.79 0.83 3.3 78 F 26 3.5 14 
        
0.89 0.94 4.1 50 F 20 2.0 15 
0.93 1.00 4.2 40 F 17 3.4 16 
1.03 1.12 3.8 47 M 26 2.2 15 
        
1.33 1.40 3.6 68 F 22 2.7 14 
1.40 1.49 4.1 43 F 22 4.4 15 
1.56 1.81 4.0 53 F 21 4.2 15 
 
Similar to Table 2, the data in Table 3 fails to show a relationship between enPCR and serum 
albumin, or enPCR and malnutrition risk. It should be noted that this analysis has numerous 
limitations, particularly its small sample size and a lack of enPCR trends over time. In addition, 
it would be strengthened immensely by the inclusion of actual dietary protein intake (measured 
with food records, food frequency questionnaires, or 24-hour recalls), as well as weight trends 
(measured by % body weight gained or lost over time). Nevertheless, it does not support the 
usefulness of enPCR in practice.  
 
Interestingly, Fresenius Medical Care has provided its dietitians with enPCR interpretation tools 
(for an abbreviated version refer to Appendix A), although my observations indicate that they are 
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rarely utilized. It should also be noted that the tool is only appropriate for patients who have a 
stable dry weight and a stable albumin level of ≥3.8 g/dL. Patients who are classified as 
“unstable” require a close evaluation of enPCR alongside numerous other parameters (such as 
co-morbidities, protein status, CRP, dry weight), making its interpretation much more 
complicated.36  
 
Discussion 
 
Despite advances in medical knowledge and technology, malnutrition and PEW remain prevalent 
problems in the HD patient population. There are many challenges associated with achieving 
ideal protein intake in dialysis patients, largely because their nutritional requirements are so 
much higher than those of the general population. A study by Ekramzadeh et al. (2014) randomly 
selected and interviewed 255 patients from three dialysis centers. All patients were on HD for at 
least 3 months without acute illness, and nutritional status was measured using both SGA and 
malnutrition-inflammation scores. After exploring numerous medical, behavioral, and 
socioeconomic barriers, the authors determined that poor appetite, depression, difficulty 
chewing, poor nutrition and protein knowledge, and the need for help with shopping and cooking 
are all independently and significantly correlated with malnutrition.27 
 
Fortunately, it has been shown that at least some cases of poor protein intake and PEW can be 
reversed with aggressive supplementation.23 Although patients with evidence of ongoing 
inflammation are less likely to respond to nutritional support, research suggests that 
supplementation should still be attempted.8,33 Recent studies indicate that nutritional 
supplements, administered orally, enterally, or parenterally, are effective in replenishing both 
protein and energy stores in HD patients who are unable to maintain adequate dietary intake 
from meals alone.33 
 
Due to the pervasiveness of malnutrition in the HD population, it is important to understand the 
utility of nPCR, as well as other nutrition-related laboratory values. Further research is required 
before nPCR can play a truly valuable role in clinical practice, as indicated by the 
inconclusiveness of the above literature review. Numerous studies indicate that an nPCR 
between 1.0-1.4 g/kg/d is significantly correlated with a decreased risk of death in stable 
maintenance HD patients.13,15,16,18,28 That said, it is only reliable in patients with a dry weight that 
is close to their ideal body weight; in other words, those who are within 95-115% of standard 
body weight.17,35 This significantly limits the number of patients for which nPCR may be 
helpful; as illustrated in Table 2 and Table 3 of the mini-analysis, 50% of the subjects were 
classified as obese and therefore did not meet this criteria.   
 
In addition, none of the dietitians I interviewed regularly use nPCR in practice, as they feel as 
though it does not accurately reflect their patients’ protein intake or overall nutrition status. This 
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is despite the fact enPCR is a value that renal dietitians are expected to positively influence; it is 
even included on patient reports. Therefore, my personal experience in HD clinics aligns with the 
findings from the mini-analysis, which indicate that enPCR may not be of much use after all. 
More often than not, the enPCR value was irrelevant with regards to the patient’s plan of care. 
Instead, dietitians focused their efforts on the patient’s serum albumin, reported dietary protein 
intake, and physical appearance. These were the factors used to determine which nutritional 
interventions would be most effective and most beneficial for the patient, not enPCR.  
 
The conflicting evidence regarding nPCR and enPCR remains a dilemma for renal dietitians, as 
there is a disconnect between what the literature implies and what is seen in clinical practice. 
Therefore, it can be concluded that nPCR is not a reliable indicator of protein intake or mortality 
in HD patients. Outstanding questions include:  
 
• Is nPCR more reliable if interpreted in conjunction with one or more measures of 
nutritional status (for instance, the presence of muscle wasting, serum prealbumin, and/or 
a SGA score), as opposed to standing alone?  
• Is there a correlation between nPCR and other scientifically proven, reproducible 
measures of dietary protein intake (for instance, 24 hour recalls) and/or nutritional status 
(for instance, bioimpedance spectroscopy)? 
• It is well established that malnutrition is related to both inflammation and CVD28,23. To 
what extent is nPCR influenced by the presence of inflammatory factors (for example, 
what is its relationship to CRP or TNF-α)?  
• Should additional variables be included in the equations used to calculate nPCR; for 
instance, to account for whether a dialyzer is used once versus used multiple times? 
• Almost all of the existing literature exploring nPCR involves stable HD patients. Further 
research is needed in order to understand how well nPCR estimates protein intake and 
mortality in unstable HD patients, as these patients are typically those most at risk for 
poor intake and malnutrition.  
 
Researchers and health care providers alike have identified PEW as both a serious and persistent 
problem for maintenance HD patients.27 Consequently, it often falls on the shoulders of renal 
dietitians to address protein intake with their patients, in order to maintain or even improve 
nutritional status. Unfortunately, nPCR currently falls short as a method of estimating dietary 
protein intake in this patient population. Until further research examining the utility of nPCR has 
been completed and its limitations have been addressed, dietitians should continue to rely on 
other measures when assessing malnutrition in HD patients. Using dietary recalls, physical 
examinations, and better-supported laboratory values, dietitians can help their patients achieve a 
protein intake that replenishes the protein lost during each dialysis treatment, preserves lean body 
mass, and decreases risk of death.    
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Appendix A: Interpretation of enPCR in Stable HD Patients36 
enPCR 
(g/kg/day) 
Interpretation Intervention 
<0.8 • Low protein intake 
• Mild negative nitrogen balance 
• May indicate unmeasured residual 
renal function 
• Counsel patient to increase protein & calorie 
intake to recommendations 
• Begin supplements 
0.8-1.3 • Adequate protein intake 
• Neutral nitrogen balance 
• Encourage patient to continue current intake 
>1.3 • Excessive protein intake 
OR 
• Severe catabolism  
• Consider increasing dialysis dose to support a 
higher protein intake 
• If catabolic, counsel patient to increase protein 
& calorie intake to recommendations and 
begin supplements 
 
